This is the authors' abstract. We don't add key points for this paper.
Transition metal complexes featuring unusual oxidation states represent an exciting frontier in inorganic chemistry. This review surveys the unusual oxidation states of two biologically important metals, platinum (Pt I and Pt III ) and gold (Au II ), examining their electronic structures, bonding characteristics, and biomedical relevance, among other features. Emphasis is placed on synthetic strategies, redox behavior, and factors influencing their stability and stabilization. Pt III complexes can potentially offer an alternative to the traditional Pt II/IV anticancer chemotherapy framework and be an intermediate in Pt II/IV redox chemistry. Indeed, the Pt III -based platinum blues have been widely investigated as anticancer agents soon after the landmark discovery of cisplatin as a cancer chemotherapeutic. Au II complexes are less explored for their biological properties but may be intermediates in Au I/III redox chemistry and offer an alternative pathway to gold-based chemotherapeutics. We outline current challenges and future directions in this evolving field, where fundamental chemistry meets therapeutic innovation.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ojha et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: